Publication | Open Access

A feasibility study of sequential doublet chemotherapy comprising carboplatin–doxorubicin and carboplatin–paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma

MedicineSequential Doublet ChemotherapyAdvanced Endometrial AdenocarcinomaCancer ManagementGynecologyFeasibility StudyCancer TreatmentOncologyRadiation OncologyGynecology OncologyMolecular Oncology